Switch to:
More From Other Websites
Novogen (NVGN) Conducts Scientific Review of R&D Program Aug 31 2015
Novogen Announces The Outcome Of A Comprehensive Science Review Aug 30 2015
Newly Appointed Acting CEO Outlines Immediate Plans for Novogen Jul 29 2015
Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the Board Jul 21 2015
Anisina Receives Orphan Drug Designation from FDA for Neuroblastoma Jul 16 2015
Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood Cancer Jul 13 2015
H.C. Wainwright: Time To Buy Novogen Jul 01 2015
Coverage initiated on Novogen by H.C. Wainwright Jul 01 2015
Novogen Announces the Chairman's Address at the Company's General Meeting Jun 23 2015
Anisina on Track to Enter Clinic in 2016 Jun 23 2015
StockNewsNow.com Publishes New SNNLive Video Interview With Novogen Limited Jun 16 2015
Novogen to Present at Bio International Convention Philadelphia 2015 Jun 11 2015
Studies Confirm TRXE-009 Crosses the Blood-brain Barrier Jun 04 2015
Novogen Expands Board with Two New Appointments Jun 02 2015
Novogen Limited Announces Closing of Rights Issue Entitlement Offer and Notice of Shortfall Jun 01 2015
ATM Technology Extended with New Patent Lodgement May 27 2015
Novogen to Present at Brain Tumor Biotech Summit 2015 May 26 2015
Novogen to Present at the 2015 Marcum Microcap Conference May 25 2015
Novogen to Present at Hong Kong Investor Conference May 17 2015
Anisina Confirmed as Effective Anti-Cancer Agent in Animal Studies May 13 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK